Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Europe and Middle East & Africa Gastrointestinal Testing Panels Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, 2017–2031

5. Key Insights
5.1. Gastrointestinal Disorders: Overview
5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by Pathogen Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Pathogen Type, 2017–2031
6.3.1. Viruses
6.3.2. Bacteria
6.3.3. Parasites

7. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2017–2031
7.3.1. Syndromic Full Multiplex Panel
7.3.2. Low Plex Panel
7.4. Market Attractiveness Analysis, by Type

8. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Point-of-Care
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user

9. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. Europe
9.2.2. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region

10. Europe Gastrointestinal Testing Panels Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Pathogen Type, 2017–2031
10.2.1. Viruses
10.2.2. Bacteria
10.2.3. Parasites
10.3. Market Value Forecast, by Type, 2017–2031
10.3.1. Syndromic Full Multiplex Panel
10.3.2. Low Plex Panel
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Point-of-Care
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. Germany
10.5.1.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.1.1.1. Viruses
10.5.1.1.2. Bacteria
10.5.1.1.3. Parasites
10.5.1.2. Market Value Forecast, by Type, 2017–2031
10.5.1.2.1. Syndromic Full Multiplex Panel
10.5.1.2.2. Low Plex Panel
10.5.1.3. Market Value Forecast, by End-user, 2017–2031
10.5.1.3.1. Hospitals
10.5.1.3.2. Diagnostic Laboratories
10.5.1.3.3. Point-of-Care
10.5.1.3.4. Others
10.5.2. U.K.
10.5.2.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.2.1.1. Viruses
10.5.2.1.2. Bacteria
10.5.2.1.3. Parasites
10.5.2.2. Market Value Forecast, by Type, 2017–2031
10.5.2.2.1. Syndromic Full Multiplex Panel
10.5.2.2.2. Low Plex Panel
10.5.2.3. Market Value Forecast, by End-user, 2017–2031
10.5.2.3.1. Hospitals
10.5.2.3.2. Diagnostic Laboratories
10.5.2.3.3. Point-of-Care
10.5.2.3.4. Others
10.5.3. France
10.5.3.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.3.1.1. Viruses
10.5.3.1.2. Bacteria
10.5.3.1.3. Parasites
10.5.3.2. Market Value Forecast, by Type, 2017–2031
10.5.3.2.1. Syndromic Full Multiplex Panel
10.5.3.2.2. Low Plex Panel
10.5.3.3. Market Value Forecast, by End-user, 2017–2031
10.5.3.3.1. Hospitals
10.5.3.3.2. Diagnostic Laboratories
10.5.3.3.3. Point-of-Care
10.5.3.3.4. Others
10.5.4. Italy
10.5.4.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.4.1.1. Viruses
10.5.4.1.2. Bacteria
10.5.4.1.3. Parasites
10.5.4.2. Market Value Forecast, by Type, 2017–2031
10.5.4.2.1. Syndromic Full Multiplex Panel
10.5.4.2.2. Low Plex Panel
10.5.4.3. Market Value Forecast, by End-user, 2017–2031
10.5.4.3.1. Hospitals
10.5.4.3.2. Diagnostic Laboratories
10.5.4.3.3. Point-of-Care
10.5.4.3.4. Others
10.5.5. Spain
10.5.5.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.5.1.1. Viruses
10.5.5.1.2. Bacteria
10.5.5.1.3. Parasites
10.5.5.2. Market Value Forecast, by Type, 2017–2031
10.5.5.2.1. Syndromic Full Multiplex Panel
10.5.5.2.2. Low Plex Panel
10.5.5.3. Market Value Forecast, by End-user, 2017–2031
10.5.5.3.1. Hospitals
10.5.5.3.2. Diagnostic Laboratories
10.5.5.3.3. Point-of-Care
10.5.5.3.4. Others
10.5.6. Benelux
10.5.6.1.1. Viruses
10.5.6.1.2. Bacteria
10.5.6.1.3. Parasites
10.5.6.2. Market Value Forecast, by Type, 2017–2031
10.5.6.2.1. Syndromic Full Multiplex Panel
10.5.6.2.2. Low Plex Panel
10.5.6.3. Market Value Forecast, by End-user, 2017–2031
10.5.6.3.1. Hospitals
10.5.6.3.2. Diagnostic Laboratories
10.5.6.3.3. Point-of-Care
10.5.6.3.4. Others
10.5.7. Poland
10.5.7.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.7.1.1. Viruses
10.5.7.1.2. Bacteria
10.5.7.1.3. Parasites
10.5.7.2. Market Value Forecast, by Type, 2017–2031
10.5.7.2.1. Syndromic Full Multiplex Panel
10.5.7.2.2. Low Plex panel
10.5.7.3. Market Value Forecast, by End-user, 2017–2031
10.5.7.3.1. Hospitals
10.5.7.3.2. Diagnostic Laboratories
10.5.7.3.3. Point-of-Care
10.5.7.3.4. Others
10.5.8. Norway
10.5.8.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.8.1.1. Viruses
10.5.8.1.2. Bacteria
10.5.8.1.3. Parasites
10.5.8.2. Market Value Forecast, by Type, 2017–2031
10.5.8.2.1. Syndromic Full Multiplex Panel
10.5.8.2.2. Low Plex Panel
10.5.8.3. Market Value Forecast, by End-user, 2017–2031
10.5.8.3.1. Hospitals
10.5.8.3.2. Diagnostic Laboratories
10.5.8.3.3. Point-of-Care
10.5.8.3.4. Others
10.5.9. Sweden
10.5.9.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.9.1.1. Viruses
10.5.9.1.2. Bacteria
10.5.9.1.3. Parasites
10.5.9.2. Market Value Forecast, by Type, 2017–2031
10.5.9.2.1. Syndromic Full Multiplex Panel
10.5.9.2.2. Low Plex Panel
10.5.9.3. Market Value Forecast, by End-user, 2017–2031
10.5.9.3.1. Hospitals
10.5.9.3.2. Diagnostic Laboratories
10.5.9.3.3. Point-of-Care
10.5.9.3.4. Others
10.5.10. Denmark
10.5.10.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.10.1.1. Viruses
10.5.10.1.2. Bacteria
10.5.10.1.3. Parasites
10.5.10.2. Market Value Forecast, by Type, 2017–2031
10.5.10.2.1. Syndromic Full Multiplex Panel
10.5.10.2.2. Low Plex Panel
10.5.10.3. Market Value Forecast, by End-user, 2017–2031
10.5.10.3.1. Hospitals
10.5.10.3.2. Diagnostic Laboratories
10.5.10.3.3. Point-of-Care
10.5.10.3.4. Others
10.5.11. Finland
10.5.11.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.11.1.1. Viruses
10.5.11.1.2. Bacteria
10.5.11.1.3. Parasites
10.5.11.2. Market Value Forecast, by Type, 2017–2031
10.5.11.2.1. Syndromic Full Multiplex Panel
10.5.11.2.2. Low Plex Panel
10.5.11.3. Market Value Forecast, by End-user, 2017–2031
10.5.11.3.1. Hospitals
10.5.11.3.2. Diagnostic Laboratories
10.5.11.3.3. Point-of-Care
10.5.11.3.4. Others
10.5.12. Austria
10.5.12.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.12.1.1. Viruses
10.5.12.1.2. Bacteria
10.5.12.1.3. Parasites
10.5.12.2. Market Value Forecast, by Type, 2017–2031
10.5.12.2.1. Syndromic Full Multiplex Panel
10.5.12.2.2. Low Plex Panel
10.5.12.3. Market Value Forecast, by End-user, 2017–2031
10.5.12.3.1. Hospitals
10.5.12.3.2. Diagnostic Laboratories
10.5.12.3.3. Point-of-Care
10.5.12.3.4. Others
10.5.13. Switzerland
10.5.13.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.13.1.1. Viruses
10.5.13.1.2. Bacteria
10.5.13.1.3. Parasites
10.5.13.2. Market Value Forecast, by Type, 2017–2031
10.5.13.2.1. Syndromic Full Multiplex Panel
10.5.13.2.2. Low Plex Panel
10.5.13.3. Market Value Forecast, by End-user, 2017–2031
10.5.13.3.1. Hospitals
10.5.13.3.2. Diagnostic Laboratories
10.5.13.3.3. Point-of-Care
10.5.13.3.4. Others
10.5.14. Rest of Europe
10.5.14.1. Market Value Forecast, by Pathogen Type, 2017–2031
10.5.14.1.1. Viruses
10.5.14.1.2. Bacteria
10.5.14.1.3. Parasites
10.5.14.2. Market Value Forecast, by Type, 2017–2031
10.5.14.2.1. Syndromic Full Multiplex Panel
10.5.14.2.2. Low Plex Panel
10.5.14.3. Market Value Forecast, by End-user, 2017–2031
10.5.14.3.1. Hospitals
10.5.14.3.2. Diagnostic Laboratories
10.5.14.3.3. Point-of-Care
10.5.14.3.4. Others
10.6. Market Attractiveness Analysis
10.6.1. By Pathogen Type
10.6.2. By Type
10.6.3. By End-user
10.6.4. By Country

11. Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Pathogen Type, 2017–2031
11.2.1. Viruses
11.2.2. Bacteria
11.2.3. Parasites
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. Syndromic Full Multiplex Panel
11.3.2. Low Plex Panel
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Point-of-Care
11.4.4. Others
11.5. Market Value Forecast, by Country, 2017–2031
11.5.1. GCC Countries
11.5.1.1. Market Value Forecast, by Pathogen Type, 2017–2031
11.5.1.1.1. Viruses
11.5.1.1.2. Bacteria
11.5.1.1.3. Parasites
11.5.1.2. Market Value Forecast, by Type, 2017–2031
11.5.1.2.1. Syndromic Full Multiplex Panel
11.5.1.2.2. Low Plex Panel
11.5.1.3. Market Value Forecast, by End-user, 2017–2031
11.5.1.3.1. Hospitals
11.5.1.3.2. Diagnostic Laboratories
11.5.1.3.3. Point-of-Care
11.5.1.3.4. Others
11.5.2. South Africa
11.5.2.1. Market Value Forecast, by Pathogen Type, 2017–2031
11.5.2.1.1. Viruses
11.5.2.1.2. Bacteria
11.5.2.1.3. Parasites
11.5.2.2. Market Value Forecast, by Type, 2017–2031
11.5.2.2.1. Syndromic Full Multiplex Panel
11.5.2.2.2. Low Plex Panel
11.5.2.3. Market Value Forecast, by End-user, 2017–2031
11.5.2.3.1. Hospitals
11.5.2.3.2. Diagnostic Laboratories
11.5.2.3.3. Point-of-Care
11.5.2.3.4. Others
11.5.3. Rest of Middle East & Africa
11.5.3.1. Market Value Forecast, by Pathogen Type, 2017–2031
11.5.3.1.1. Viruses
11.5.3.1.2. Bacteria
11.5.3.1.3. Parasites
11.5.3.2. Market Value Forecast, by Type, 2017–2031
11.5.3.2.1. Syndromic Full Multiplex Panel
11.5.3.2.2. Low Plex Panel
11.5.3.3. Market Value Forecast, by End-user, 2017–2031
11.5.3.3.1. Hospitals
11.5.3.3.2. Diagnostic Laboratories
11.5.3.3.3. Point-of-Care
11.5.3.3.4. Others
11.6. Market Attractiveness Analysis
11.6.1. By Pathogen Type
11.6.2. By Type
11.6.3. By End-user
11.6.4. By Country

12. Competition Landscape
12.1. Company Profiles
12.1.1. Becton, Dickinson and Company (BD)
12.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.1.2. Product Portfolio
12.1.1.3. SWOT Analysis
12.1.1.4. Strategic Overview
12.1.2. bioM?rieux SA
12.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.2.2. Product Portfolio
12.1.2.3. SWOT Analysis
12.1.2.4. Strategic Overview
12.1.3. DiaSorin S.p.A (Luminex)
12.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.3.2. Product Portfolio
12.1.3.3. SWOT Analysis
12.1.3.4. Strategic Overview
12.1.4. Quidel Corporation
12.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.4.2. Product Portfolio
12.1.4.3. SWOT Analysis
12.1.4.4. Strategic Overview
12.1.5. QIAGEN
12.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.5.2. Product Portfolio
12.1.5.3. SWOT Analysis
12.1.5.4. Strategic Overview
12.1.6. Seegene, Inc.
12.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.6.2. Product Portfolio
12.1.6.3. SWOT Analysis
12.1.6.4. Strategic Overview
12.1.7. Savyon Diagnostics
12.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.7.2. Product Portfolio
12.1.7.3. SWOT Analysis
12.1.7.4. Strategic Overview
12.1.8. CerTest Biotech S.L.
12.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.8.2. Product Portfolio
12.1.8.3. SWOT Analysis
12.1.8.4. Strategic Overview
12.1.9. Anatolia Geneworks
12.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
12.1.9.2. Product Portfolio
12.1.9.3. SWOT Analysis
12.1.9.4. Strategic Overview



List of Figures

 

Figure 01: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by Type, 2020

Figure 03: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by Region, 2020

Figure 04: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by Pathogen Type, 2020

Figure 05: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by End-user, 2020

Figure 06: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 07: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 08: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Viruses, 2017–2031

Figure 09: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Bacteria, 2017–2031

Figure 10: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Parasites, 2017–2031

Figure 11: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 12: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 13: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Syndromic Full Multiplex Panel, 2017–2031

Figure 14: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Low Plex Panel, 2017–2031

Figure 15: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 16: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 17: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 18: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Diagnostic Laboratories, 2017–2031

Figure 19: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Point-of-Care, 2017–2031

Figure 20: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Others, 2017–2031

Figure 21: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Region, 2020 and 2031

Figure 22: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Region, 2021–2031

Figure 23: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 24: Europe Gastrointestinal Testing Panels Market Value Share, by Country/Sub-region, 2020–2031

Figure 25: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 26: Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 27: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 28: Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 29: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 30: Europe Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 31: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 32: Germany Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 33: Germany Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 34: Germany Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 35: Germany Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 36: Germany Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 37: Germany Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 38: U.K. Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 39: U.K. Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 40: U.K. Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 41: U.K. Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 42: U.K. Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 43: U.K. Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 44: France Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 45: France Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 46: France Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 47: France Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 48: France Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 49: France Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 50: Italy Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 51: Italy Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 52: Italy Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 53: Italy Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 54: Italy Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 55: Italy Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 56: Spain Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 57: Spain Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 58: Spain Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 59: Spain Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 60: Spain Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 61: Spain Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 62: Benelux Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 63: Benelux Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 64: Benelux Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 65: Benelux Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 66: Benelux Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 67: Benelux Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 68: Poland Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 69: Poland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 70: Poland Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 71: Poland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 72: Poland Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 73: Poland Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 74: Norway Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 75: Norway Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 76: Norway Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 77: Norway Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 78: Norway Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 79: Norway Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 80: Sweden Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 81: Sweden Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 82: Sweden Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 83: Sweden Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 84: Sweden Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 85: Sweden Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 86: Denmark Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 87: Denmark Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 88: Denmark Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 89: Denmark Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 90: Denmark Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 91: Denmark Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 92: Finland Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 93: Finland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 94: Finland Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 95: Finland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 96: Finland Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 97: Finland Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 98: Austria Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 99: Austria Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 100: Austria Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 101: Austria Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 102: Austria Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 103: Austria Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 104: Switzerland Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 105: Switzerland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 106: Switzerland Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 107: Switzerland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 108: Switzerland Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 109: Switzerland Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 110: Rest of Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 111: Rest of Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 112: Rest of Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 113: Rest of Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 114: Rest of Europe Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 115: Rest of Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 116: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 117: Middle East & Africa Gastrointestinal Panel Testing Market Value Share, by Country/Sub-region, 2020–2031

Figure 118: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 119: Middle East & Africa Gastrointestinal Panel Testing Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 120: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 121: Middle East & Africa Gastrointestinal Panel Testing Market Value Share Analysis, by Type, 2020 and 2031

Figure 122: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by Type, 2021–2031

Figure 123: Middle East & Africa Gastrointestinal Panel Testing Market Value Share Analysis, by End-user, 2020 and 2031

Figure 124: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by End-user, 2021–2031

Figure 125: GCC Countries Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 126: GCC Countries Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 127: GCC Countries Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 128: GCC Countries Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 129: GCC Countries Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 130: GCC Countries Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 131: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 132: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 134: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 135: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 136: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 137: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 138: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 139: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 140: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 141: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 142: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 143: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

List of Tables


Table 01: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 02: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 03: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 06: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 07: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 08: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Germany Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 10: Germany Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 11: Germany Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: U.K. Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 13: U.K. Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 14: U.K. Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: France Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 16: France Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 17: France Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Italy Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 19: Italy Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 20: Italy Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Spain Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 22: Spain Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 23: Spain Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 24: Benelux Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 25: Benelux Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 26: Benelux Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 27: Poland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 28: Poland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 29: Poland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 30: Norway Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017?2031

Table 31: Norway Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 32: Norway Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 33: Sweden Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017?2031

Table 34: Sweden Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 35: Sweden Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 36: Denmark Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017?2031

Table 37: Denmark Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 38: Denmark Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 39: Finland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017?2031

Table 40: Finland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 41: Finland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 42: Austria Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017?2031

Table 43: Austria Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 44: Austria Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 45: Switzerland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017?2031

Table 46: Switzerland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 47: Switzerland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 48: Rest of Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017?2031

Table 49: Rest of Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 50: Rest of Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 51: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 52: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 53: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 54: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 55: GCC Countries Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017?2031

Table 56: GCC Countries Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 57: GCC Countries Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 58: South Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017?2031

Table 59: South Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 60: South Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 61: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 62: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 63: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031